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Abstract: The benefits of the Mediterranean diet (MD) for protecting against chronic
disorders such as cardiovascular disease are usually attributed to high consumption of certain
food groups such as vegetables, and low consumption of other food groups such as meat. The
influence of food processing techniques such as food preparation and cooking on the nutrient
composition and nutritional value of these foods is not generally taken into consideration. In
this narrative review, we consider the mechanistic and epidemiological evidence that food
processing influences phytochemicals in selected food groups in the MD (olives, olive oil,
vegetables and nuts), and that this influences the protective effects of these foods against
chronic diseases associated with inflammation. We also examine how the pro-inflammatory
properties of meat consumption can be modified by Mediterranean cuisine. We conclude
by discussing whether food processing should be given greater consideration, both when
recommending a MD to the consumer and when evaluating its health properties.
Keywords: Mediterranean diet; food processing; food preparation; cooking;
phytochemicals; inflammation; oxidative stress
1. Introduction
Food preparation and cooking influence the nutritional qualities of foods, and potentially their health
benefits. These processes can have beneficial effects, for example by improving the digestibility and
bioavailability of nutrients, and by enhancing attractiveness to the consumer because of improved texture
and taste [1], and also deleterious effects due to loss of nutrients or the formation of toxic compounds [2].
The Mediterranean diet (MD) is well-known for its health benefits and this diet is increasingly being
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recommended in non-Mediterranean countries [3]. However, food preparation and cooking customs in
non-Mediterranean countries may be quite different from those in Mediterranean countries. This is rarely
considered when applying findings on the MD derived from one population to a different population with
a different cuisine, and the extent to which differences in food preparation practices between populations
impacts on the nutritional qualities of the MD is not well understood.
The traditional MD is characterized by plenty of fruits, vegetables and nuts, legumes, cereals
(preferably whole grain), herbs and spices, fish and seafood, moderate amounts of meat and dairy
produce (mainly from sheep and goats), olive oil (for dressing and cooking) and moderate amounts
of wine with meals [4]. This rich diversity of foods results in the MD having a unique compendium
of nutrients that contributes to its protective effects against chronic disease [5,6]. Because the MD is
essentially a plant-based diet, phytochemicals are considered to be major contributors to the overall
health benefits of this diet [7], and this group of nutrients is strongly influenced by food preparation
and cooking [8,9]. A major property of phytochemicals that contributes to their health benefits is their
ability to reduce oxidative stress and inflammation (reviewed in [10]), and a reduction in inflammation
by phytochemicals has been linked to the benefits of phytochemicals for the MD [11].
In this review, we first consider the anti-inflammatory effects of the MD, and we then go on to
discuss antioxidant and anti-inflammatory phytochemicals in some of the main food groups of the
MD (olives and olive oil, vegetables and nuts). We then discuss how these phytochemicals are
influenced by food preparation and cooking and the effects of these processes on health outcomes.
Since the overall oxidative stress and inflammation in the body is due to factors that increase as well as
decrease oxidative stress and inflammation, we also consider food preparation and cooking procedures
that are pro-oxidant and pro-inflammatory, particularly in relation to meat. Because some traditional
Mediterranean cooking practices may be less common in non-Mediterranean countries, we conclude
by discussing whether advice on food preparation should be given when recommending the MD in
non-Mediterranean countries.
2. Oxidation, Inflammation and the MD
Inflammation is now recognized as a major factor in the pathology of many chronic diseases including
cardiovascular disease (CVD), cancer, type 2 diabetes, metabolic syndrome and Alzheimer’s disease,
and inflammation is also associated with obesity [10,12–15]. The inflammation that contributes to
these diseases may occur systemically in the body, such as the low grade chronic inflammation that
is also linked with aging (inflammaging) and obesity, or it may be more localized. Another source of
inflammation with potentially harmful consequences is the acute inflammation that can occur during the
postprandial state as a result of hyperlipemia and hyperglycemia [16].
A number of epidemiological studies have demonstrated that consuming a MD reduces
inflammation [14]. Barbaresko and colleagues in a recent systematic review reported that among a priori
healthy dietary patterns, the MD was the most consistent in showing a decrease in C reactive protein
(CRP) and an increase in adiponectin [17]. In the large Italian Moli-sani study, a decrease in white
blood cell and platelet counts (measured as markers of low grade inflammation) was shown to be
associated with a greater adherence to a Mediterranean-like diet [18]. Adherence to a traditional MD
was also shown to be associated with a reduction of CRP and IL-6 in survivors of a myocardial infarct,
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independently of the medication [19]. The potential role of the MD in reducing low grade chronic
inflammation in the elderly (inflammaging) is currently being studied in the NU-AGE project [20].
As well as low grade inflammation, there is also good evidence that consuming a MD reduces
postprandial inflammation [21–23], and the postprandial oxidative stress that can result from
postprandial hyperglycemia and hyperlipemia [23]. One link between oxidative stress and inflammation
is through the transcription factors NF-κB. This is because NF-κB is induced by oxidative stress, which
in turn increases the expression of pro-inflammatory genes for cytokines and chemokines [24]. Hence,
not surprisingly, antioxidant phytochemicals can reduce inflammatory responses. For example, in a short
term intervention it was shown that polyphenols from virgin olive oil (VOO) decreased postprandial
gene expression of the NF-κB-mediated pro-inflammatory cytokines IL1B, IL6 and CXCL1 in peripheral
blood mononuclear cells [22]. In the Predimed (Prevención con Dieta Mediterránea) study, adherence to
a MD was associated with increased total antioxidant capacity (TAC) [25], and high dietary anti-oxidant
levels lowered CRP and IL-6 [26]. Total dietary antioxidants independently explained the relationship
between adherence to a MD pattern with better health-related quality of life (especially mental rather
than physical health) in the Moli-sani study [27].
Many of the nutrients, such as saturated fats, trans fats and refined carbohydrates, that are associated
in in vitro models with inflammatory responses are present at far lower levels in the MD than are typically
found in the western diet [28]. In order to quantify the overall inflammatory potential of dietary patterns,
a Dietary Inflammatory Index (DII) has been developed [29]. The DII is computed from the inflammatory
activity of 45 foods and nutrients. Some studies suggest that DII is positively associated with an increased
risk of various diseases such as pancreatic cancer [30] and colon cancer [31]. Using data from the
Predimed study, a DII was computed from a measure of adherence to the MD (a MD score) and, as
expected, the MD score was found to be inversely associated with DII [32]. In this cross-sectional
analysis of the Predimed study, a lower DII was associated with a lower prevalence of obesity [32]
and in a prospective one with incidence of CVD [33]. Based on nutritional data from Luxembourg,
higher adherence to a MD score was associated with a favorable cardio-metabolic, hepatic and renal
risk profile, whereas the relationship with DII was weaker suggesting that other foods and nutrients
than the ones used in the construction of the DII are necessary for greater prevention [34]. Hence, in
summary, it can be concluded that there is good evidence that antioxidant phytochemicals in the MD
have anti-inflammatory effects in the body, and there is increasing evidence that this is important for the
health benefits of the MD.
3. Food Processing and Phytochemicals—General Considerations
When establishing associations between adherence to the MD and the inflammatory status of the diet
(e.g., using DII), the nutritional data are based on food composition tables that usually do not take into
consideration possible effects of food preparation and cooking. Loss of anti-oxidant phytochemicals
can occur during cooking due to thermal degradation and from leaching of substances (especially of
more polar compounds) into the cooking medium. As well as loss of antioxidants, the formation of
pro-oxidants can occur, especially when cooking at high temperatures, notably as a consequence of the
Maillard reaction. Food preparation can also have beneficial effects by increasing the bioavailability of
antioxidant phytochemicals [35]. For some phytochemicals, this is because of enhanced release from
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the food matrix, although the extent to which this occurs may vary widely. Carotenoids can be released
from their association with proteins inside chromoplasts, and folate from proteins [36,37]. However,
some polyphenols such as phenolic acids are more tightly bound to dietary fiber and protein [38]. Bound
polyphenols can constitute a significant proportion of total daily intake. In fruits (apples, peaches and
nectarines), 80%–90% of polyphenols were in the bound form [39], and it was estimated that bound
polyphenols constituted 78% of the total phenolics in the Spanish diet [40]. Hence, factors that release
bound polyphenols may have a significant impact on the overall level of bioavailable polyphenols. Poor
bioavailability is not, however, necessarily detrimental. Components of the food matrix can act as carriers
enabling phytochemicals to reach the colon where they may be released by the actions of gut bacteria.
For example, grain fiber carries polyphenols to the colon and releasing polyphenols here, rather than
higher up the gastrointestinal tract, may have health benefits either in the colon itself or after being
absorbed there into the body [41,42].
Because it is difficult to predict the consequences on health of food processing simply based on model
systems, we consider a wide range of studies (biochemical studies, biomarkers and health outcomes)
that address how food processing may influence both the bioavailability and health consequences of
consuming antioxidant and anti-inflammatory phytochemicals present in the main foods groups of
the MD.
4. Olive Oil and Olives
Antioxidant and anti-inflammatory compounds in extra virgin olive oil (EVOO) include tocopherols,
carotenoids and polyphenols. Polyphenols are especially important because of their number, diversity
and particular properties. At least 36 phenolic compounds have so far been identified in EVOO [43].
The most abundant polyphenols in EVOO include secoiridoids such as oleuropein derivatives (especially
the dialdehydic form of decarboxymethyl elenolic acid linked to hydroxytyrosol), phenolic derivatives
of secoiridoids such as tyrosol and hydroxytyrosol, lignans, flavonoids, and decarboxy methyl
ligstroside aglycone—known as oleocanthal [44,45]. The antioxidant activities of EVOOs have been
shown to correlate with their polyphenol content [46,47], one study finding a better correlation with
diphenol content than with overall phenol content [47]. Ortho-diphenols such as hydroxytyrosol and
oleuropein derivatives are more potent phenolic antioxidants [46,48]. Oleocanthal is an inhibitor
of cyclooxygenase activity and is best known for its anti-inflammatory properties [44]. The major
polyphenols hydroxytyrosol and tyrosol have high bioavailability (40%–95%) when present in olive
oil [49], although there is less information for other EVOO polyphenols.
The health benefits of olive oil have been extensively reviewed [50–52]. When compared with
olive oils with low polyphenol concentrations, most clinical studies demonstrated that olive oils
containing high polyphenol concentrations resulted in greater reductions in inflammatory biomarkers,
better protection of low-density lipoprotein-cholesterol (LDL-cholesterol) from oxidation, and greater
decreases in isoprostanes [43]. EVOO has been shown to be superior to ordinary olive oil (which is
lower in polyphenols) in preventing CVD [53]. Although there is suggestive evidence for a protective
effect of olive oil against breast cancer [54], studies have not distinguished between ordinary olive
oil and EVOO. The antioxidant properties of polyphenols are implicated in reducing CVD and some
cancers (with levels of evidence categorized as possible to probable) by preventing LDL oxidation
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and neutralizing free radicals respectively [55]. The anti-inflammatory properties of polyphenols from
EVOO may also contribute to these beneficial effects [56]. Oleocanthal has neuro-protective effects and
attenuates markers of inflammation implicated in Alzheimer’s disease, and has also been shown to have
anti-proliferative effects against human breast and prostate cancer cell lines [44,57].
Table olives are extremely rich sources of antioxidant polyphenols, comprising 1%–3% of the fresh
pulp weight [48]. For most types of olives, the major polyphenols are oleuropein and hydroxytyrosol.
In one study, levels of hydroxytyrosol were estimated to be 250–760 mg/kg in Kalamata olives,
170–510 mg/kg in Spanish-style green olives, and 100–340 mg/kg in Greek-style naturally black
olives [58]. Thus, one Kalamata olive (4 g flesh) provides approx. 1–3 mg of hydroxytyrosol. In
comparison, data from the Phenol-Explorer database gives an average content in EVOO of 7.7 mg
hydroxytyrosol/kg oil [59]. Not surprisingly, olive extracts exhibit high antioxidant activity in in vitro
assays [60,61]. Despite the high levels of hydroxytyrosol in table olives compared to EVOO, the
bioavailability in humans of hydroxytyrosol and other polyphenols from table olives is currently
unknown and to the best of our knowledge there are no human studies on their health effects, possibly
because of their frequent high salt content (although this can be reduced by rinsing).
4.1. Effects of Processing
Concentrations of total polyphenols in olive oils vary considerably—between 50 to 800 mg/kg
depending on the quality and type of the oil [62]. The extraction technique is generally considered
to have the greatest impact; the first extraction at low temperatures produces virgin olive oil and this has
the highest level of polyphenols. However, other factors also influence polyphenol levels including the
geographical location, growing conditions and cultivar of the olive trees, ripeness of the olive at harvest,
possible infestation with the olive fly, extraction method for the oil, and storage of the oil [46]. For
example, a 13-fold difference in diphenol content was found between EVOOs from different cultivars
from various regions in Italy [47].
Antioxidant levels in table olives also vary widely. A 10-fold or more difference was found in levels of
hydroxytyrosol between olive cultivars [48]. The production method for the olives is also very influential.
Particularly dramatic is the almost complete loss of hydroxytyrosol, due to oxidation and polymerization,
during the California-style oxidation method for converting green olives into black olives [48,63]. Pitting
of olives is also influential: an additional washing step is required when olives are pitted, and this process
was found to almost half the content of hydroxytyrosol that had been present in the un-pitted olives [64].
In relation to olive oil, a major influence for the consumer is how the oil is used for cooking. Common
domestic cooking conditions include shallow frying (which is at approx. 140–160 ˝C), in soups and stews
(which may include an initial frying period, followed by boiling at 100 ˝C or at a higher temperature
if the dish is cooked in the oven), and as an addition towards the end of cooking, for example in the
“lathera” dishes from Greece and Turkey. In Portugal, vegetable soups with added olive oil are very
popular, and in a study that mimicked domestic conditions there was found to be less loss of tyrosol and
hydroxytyrosol from the oil and phenolics from the vegetables if the oil was added towards the end of
the cooking period rather than at the beginning [65]. However, not all studies have replicated conditions
likely to be encountered during normal domestic cooking.
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When olive oil is used for frying, the stability of olive oil polyphenols is strongly influenced by
cooking temperature and time, the type of food present and the composition of the oil (including
antioxidants and polyunsaturated fatty acid (PUFA) content) [52,66]. In a study that simulated frying
by heating olive oil (although in the absence of food) to 180 ˝C, there was a significant decrease in
hydroxytyrosol derivatives (60% reduction after 30 min and 90% reduction after 60 min) [67]. Similar
results were reported for the mass-produced Bertolli EVOO [68]. A study from Spain found far higher
loss of hydroxytyrosol derivatives from oils made from Arbequina olives than for Piqual olives [69], and
it has been suggested that the higher rates of loss may reflect a higher PUFA (linoleic acid) content of
oils derived from Arbequina olives [66].
In contrast to the secoiridoids, lignans and oleocanthal are relatively heat stable [69]. For example,
12 frying cycles of 10 min each at 180 ˝C only reduced oleocanthal levels by 20% [70], although the
degree of loss may depend on the initial concentration of oleocanthal in the oil [71].
In a short term human study that compared the effects of heated oils on the postprandial inflammatory
response in obese subjects, VOO repeatedly heated to 180 ˝C was found to suppress postprandial
inflammation in obese subjects (determined as NF-κB activation in peripheral blood monocytes) [72].
Hydroxytyrosol was completely depleted by the heating process and so cannot be responsible for
the observed effect. By contrast, some other polyphenols were preserved, including about 75% of
tyrosol and 20% of oleuropein aglycones. Further work is required to establish the mechanism for
the protective effect. Other than this study, most intervention studies in humans with olive oil have
either used raw olive oil, such as EUROLIVE (the effect of olive oil consumption on oxidative damage
in European countries) with oxidized LDL-cholesterol as an endpoint, or have not specified the use of
the oil, e.g., Predimed with cardiovascular death as the primary endpoint. Moreover, none of the large
number of prospective epidemiological studies examining the health benefits of consuming olive oil
have distinguished between the consumption of raw and cooked olive oil. A recent systematic review
concluded that there is no epidemiological evidence that consuming fried foods is associated with an
increased risk of cardiovascular disease, although there was some evidence for weight gain [73]. Many
of the studies used olive oil as the frying oil, but, as the authors point out, the precise outcome is likely
to be influenced by the type of oil, frying technique (shallow frying or deep frying), frying duration and
temperature, and use of new or reused oils.
Acrylamide has been found in black olives prepared by the California-style processing method [74].
Acrylamide is classified as a probable human carcinogen by the International Agency for Research on
Cancer. Concentrations of acrylamide in California-style black olives varied between 410–512 µg/kg in
this study and these concentrations are comparable to levels of acrylamide found in French fries, a better
known dietary source of acrylamide. The acrylamide appears to be generated during the sterilization
process of the olives [74]. By comparison, in this study, Spanish olives and Greek olives were found
to have very low levels of acrylamide (<1.4 µg/kg). This is probably because these olives were not
sterilized, and this is the normal case with black olives from some countries.
4.2. Implications
The European Food Safety Authority (EFSA) recently upheld a health claim that EVOO reduces
LDL oxidation if “a minimum of 5 mg of hydroxytyrosol and its derivatives is consumed per day” [75].
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However, because information on the polyphenol content of EVOOs is not at present commonly available
to consumers, they are unlikely to know whether or not they have attained the goal recommended by
EFSA. Labeling bottles of olive oil with their content of secoiridoids and making consumers aware of
the possible losses of hydroxytyrosol due to high temperature cooking would facilitate implementing
the EFSA guideline without requiring excessive intake of olive oil. There may already be some public
understanding of possible losses of active compounds in olive oil: Portuguese consumers are apparently
aware that adding olive oil towards the end of cooking is more beneficial [65]. As well as recommending
EVOO for cooking, the use of raw EVOO could also be encouraged.
Due to the absence of human studies, there are currently no guidelines from EFSA recommending
olives as a source of hydroxytyrosol and its derivatives. However the high levels of these compounds in
certain types of olives, and because olives are mostly eaten raw, suggests that consumption of only a few
olives could achieve the EFSA recommended levels and without consuming many calories (assuming
there is good bioavailability). However, olives have markedly different levels of hydroxytyrosol and
hence specific types of olives would need to be recommended. In particular, California-style black
olives are not comparable to many other types of olives because of their low levels of hydroxytyrosol
and quite high levels of acrylamide.
Because of the good evidence that polyphenols in EVOO contribute to its health benefits, it has been
suggested that EVOO should be specifically recommended as part of a MD, rather than a more general
recommendation of “olive oil” [76]. Although concentrations of hydroxytyrosol will vary depending on
whether EVOO is consumed raw or after frying, how EVOO is used is not currently incorporated into
estimates of consumption for calculating MD scores. Upper versus lower quantiles of olive oil intake
in health studies mostly vary between 2–3 fold (see [52]). This variation is lower than the potential
influence of food processing practices on hydroxytyrosol levels. Hence, variation in usage of olive oil
is a potential confounding factor when evaluating the link between its consumption and health benefits.
However, it should be noted that several other olive oil polyphenols are more stable than hydroxytyrosol.
5. Vegetables—General
Vegetables contain a wide range of antioxidant phytochemicals. The levels of these phytochemicals
are influenced by environmental conditions such as exposure to sunshine, and by agronomic practices
such as the choice of cultivar, use of fertilizers and whether the produce is grown organically or
conventionally (see [77–79] for recent reviews). Epidemiological studies have compared the health
benefits of raw and cooked vegetables, and this is particularly relevant to the MD since consumption
of raw vegetables as a proportion of total vegetable consumption was reported to be higher in southern
cohorts from the EPIC (European Prospective Investigation into Cancer and Nutrition) study compared
to their northern counterparts [80]. In a recent review of case-control studies from Southern European
countries, both raw and cooked vegetables protected against various cancers, especially upper digestive
tract cancers, but there was greater protection with raw vegetable consumption [81]. In the case of breast
cancer, only raw was beneficial [81]. However, since this analysis was based on case-control studies, it
is possible that cases may have modified their intakes. In a large prospective study with a follow-up >
10 years, raw vegetables was the only category of fruit and vegetables that was significantly and strongly
(50%) associated with a risk reduction for stroke [82].
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Salads are a significant source of raw vegetables in the MD. In an analysis of the traditional Cretan
Mediterranean diet, salads were found to be consumed several times per week [83]. This way of eating
not only preserves heat labile nutrients, but dressing salads with olive oil, vinegar, herbs or spices
can greatly increase the antioxidant capacity of the dish. For example, the herbs lemon balm and
marjoram (1.5% w/w) increased the antioxidant capacity of a salad by 150% and 200% respectively [84].
Many herbs are consumed in high amounts in the MD compared to a typical western diet, and they
are frequently consumed raw or with minimal cooking. Herbs are particularly high in antioxidant
and anti-inflammatory compounds, especially polyphenols [84,85]. Herbs and spices contributed
significantly to the overall dietary intake of flavonols and flavones of traditional Greek cuisine, and
this was linked to their frequent consumption despite only being used in small quantities [86]. There
is increasing recognition of the importance of herbs and spices for good health [87,88], and although
herbs and spices are recommended foods in the MD, they are not currently assessed when measuring
adherence to the MD.
Cooking processes can strongly influence antioxidant phytochemical levels in fruits vegetables and
herbs [84,89]. Amongst the many ways of preparing vegetables, perhaps the most frequent and
traditional way in Mediterranean cuisine is to present the vegetables in olive oil, either by cooking
the vegetables in olive oil or by dressing the vegetables with raw oil. Olive oil enhances taste and
acceptability and, it has been proposed, is an important reason for the high levels of consumption
of vegetables in Mediterranean countries [90]. Another beneficial effect of EVOO is that when
vegetables are cooked in this medium they may absorb significant levels of antioxidants from the
oil [91]. In addition, the bioavailability and absorption of many phytochemicals in vegetables, especially
carotenoids, is significantly enhanced and this may increase the health benefits. We now consider how
food processing may influence the nutritional value of vegetables pertinent to the MD.
6. Tomato and Other Carotenoid-Containing Vegetables
The six main carotenoids usually reported to be present in human blood plasma are α-carotene,
β-carotene, lycopene, β-cryptoxanthin, zeaxanthin and lutein. In the MD, these are obtained from
a wide range of green leafy and other types of vegetables, fruits, cereals and olives [92]. Other
potentially significant, but usually overlooked, carotenoids in the MD are the red pigment capsanthin
and the yellow carotenoids crocin and crocetin. Capsanthin is the main carotenoid in red peppers and
paprika, comprising 29.2–36.2 µg/g fresh weight in red pepper [93]. This compares with levels of
lycopene—the main carotenoid in tomato—of 8.5–127.0 µg/g fresh weight [94]. The health significance
of capsanthin is not known, and it does have a rather short half life in human plasma (20 h) compared
to that of lycopene (222 h) [95]. Crocin and crocetin are the two main carotenoids in saffron and have
anti-tumor effects in in vitro and in vivo models [96]. Carotenoids are highly reactive towards oxygen
and free radicals and have antioxidant and anti-inflammatory effects in the body [97]. Lycopene also
suppresses carcinogenesis by inducing apoptosis and inhibiting proliferation and metastasis, and by
inducing cyto-protective enzymes [98].
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6.1. Food Processing
In many green leafy vegetables carotenoids are associated with proteins, whereas in carrots and
tomatoes carotenoids exist in a semi-crystalline form. Chopping, blending and cooking help release
carotenoids from the food matrix. Subsequently, carotenoids must be incorporated into lipid micelles in
the gut lumen in order to be absorbed across the gut wall. The effects of cooking techniques on levels
of carotenoids was evaluated in a meta-analysis by Murador and colleagues [99]. From the pooled data,
stewing (a widely used technique in Mediterranean cuisine) increased overall carotenoid content by 36%.
The apparent increase in carotenoid concentrations during stewing may be due to a combination of little
thermal degradation and high water loss. Other techniques either had no effect or decreased levels—by
41% in the case of frying.
Whereas chopping and the use of sauces are widely used in different national cuisines for
carotenoid-containing vegetables, especially tomatoes, it is the predominance of olive oil as the main
dietary fat that characterizes the traditional MD. There is evidence from in vitro and animal studies of
carotenoid micelle formation and uptake that olive oil enhances the bioavailability of carotenoids to a
greater extent that some other fats [100]. In particular, long chain fatty acids are superior to medium chain
fatty acids and oleic acid is superior to PUFAs (linoleic acid) [100]. There was greater bioavailability
of carotenoids (lycopene and astaxanthin) in rats given oral doses of carotenoids in olive oil compared
to corn oil [101] and higher levels of the photo-protective carotenoids lutein and zeaxanthin were found
in the eyes of rats given these carotenoids in an emulsion with olive oil compared to an emulsion of
sunflower oil or groundnut oil [102].
Despite these observations, their significance for humans is unclear since the amount of lipid
in the meal may be a more significant factor for carotenoid bioavailability than the actual lipid
composition [103]. It has been estimated that 3–5 g of dietary fat is required in order to significantly
enhance the bioavailability of dietary carotenoids [104,105]. Certainly, excluding lipid altogether can
significantly reduce carotenoid uptake. For example, cooking diced tomatoes in EVOO increased plasma
concentrations of cis-lycopene (the more biologically active isomer [106]) and trans-lycopene by 40%
and 82% respectively, whereas cooking the tomatoes without EVOO increased plasma concentrations of
cis-lycopene by only 15% and there was no increase in trans-lycopene levels [107]. Similarly, refined
olive oil enhanced the absorption of cis and trans isomers of lycopene (as determined by plasma levels
and AUC) in tomato juice in healthy volunteers compared to when the oil was absent [108].
Olive oil has also been shown to enhance the bioavailability of more polar phenolic compounds.
For example, the extraction of phenolic compounds such as chlorogenic acid and naringenin (the main
polyphenol in tomatoes) from a tomato sauce were enhanced when the tomato sauce was prepared with
VOO [109]. In a cross-over study, there was some evidence of higher bioavailability of naringenin when
human subjects were given a tomato sauce prepared with VOO compared to when they were given a
tomato sauce prepared in the absence of VOO [110]. However, in a prospective randomized, cross-over
intervention study, mechanical and thermal treatments during tomato sauce processing enhanced the
bioavailability of various phenolics including naringenin to a greater extent than added lipid (refined
olive oil) [111] Hence, added lipid may be less important for phenolic bioavailability from tomatoes
compared with lycopene bioavailability.
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A number of studies have also examined if processing tomatoes affects disease outcomes, although it
is not usually specified if the consumption of the tomatoes also included olive oil consumption. A Greek
case-control study examined the relationship between tomato consumption and risk of prostate cancer.
Olive oil is likely to have been the main dietary fat in this Mediterranean population. Intake of either
raw or cooked tomatoes reduced prostate cancer risk, although there was a significant and greater risk
reduction for cooked tomatoes (OR lowest versus highest tertile 1.91; CI 1.20–3.04 for cooked, versus
OR 1.55; CI 1.00–2.52 for raw) [112]. Chen et al. recently conducted a meta-analysis of prospective
studies of prostate cancer incidence and tomato consumption but there were too few studies on raw
and cooked tomatoes (3 studies in each category) to draw firm conclusions regarding the effects of
processing [113]. The lipid content of the meals was not known and so could be a confounding factor
in the analysis of these data. The roles of various phytochemicals in tomato as preventive agents against
prostate cancer and the importance of other dietary constituents for increasing the bioavailability of these
phytochemicals also requires clarification [114]. However, in the meta-analysis conducted by Chen et al.
there were enough studies with no heterogeneity to show that there was no association between lycopene
and prostate cancer incidence [113].
Bioavailability of carotenoids is modified by factors besides food processing such as the adiposity
of the subject, and exposure to tobacco or air pollution. This is an important aspect when assessing
risk reduction of cancers through dietary questionnaires, and, since these factors are not always taken
into consideration, this might explain some of the inconsistencies observed in epidemiological studies.
Studies using biomarkers show stronger and more significant associations between plasma carotenoids
and cancer risk than if only dietary intake of carotenoids is assessed. This has been shown clearly for the
association with breast cancer [115,116]. It is also noteworthy that the enzymes that metabolize lycopene
are polymorphic. This contributes to wide inter-individual variations in lycopene plasma levels and so
will influence health outcomes potentially associated with this carotenoid [106].
In relation to CVD, a short term study found that enhancing carotenoid bioavailability favorably
influenced biomarkers for CVD as end points. In a small (11 subjects) randomized cross-over trial, LDL
cholesterol and total cholesterol decreased significantly after the consumption of tomato with olive oil,
and this was associated with an increase of trans-lycopene and 5-cis-lycopene, respectively [108].
6.2. Implications
Food processing and the presence of fat increase carotenoid bioavailability and there is some limited
evidence that increasing carotenoid bioavailability may improve health benefits, at least in relation to
CVD. It is less clear if preparing the food with fat is superior to simply having fat in the meal. Also,
more work is needed to clarify if olive oil has benefits over other types of oils in relation to carotenoid
absorption. Nevertheless, EVOO does have the added advantage that when vegetables are fried in it they
may absorb beneficial micronutrients from the oil.
7. Cruciferous Vegetables
Cruciferous vegetables (e.g., cabbages, broccoli, cauliflower), also known as brassicas, contain a wide
range of health promoting compounds including polyphenols, carotenoids, tocopherols and vitamin C.
However, it is the presence of glucosinolates (GSLs) in crucifers that distinguishes them from other
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vegetables, and it is these compounds that have received the most attention. Most GSLs are considered
to be inactive, but when they come into contact with the enzyme myrosinase GSLs are converted into
various bioactive products including isothiocyanates and nitriles.
Sulforaphane, the breakdown product of the GSL glucoraphanin, is found in a wide range
of crucifers. Sulforaphane has anti-carcinogenic and cyto-protective effects through its ability to
activate the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf-2) that in turn induces
phase 2 metabolizing enzymes and antioxidant proteins [117,118]. In animal models, sulforaphane
protects not only against carcinogenesis but also against organ damage and various neurodegenerative
diseases [117,119]. A number of clinical studies have shown an effect of supplementation with
various crucifers or glucosinolates on factors implicated in carcinogenesis such as cytoprotective
enzymes (e.g., glutathione transferase) and markers of Helicobacter pylori colonization and gastric
inflammation [118]. Some prospective studies on breast cancer showed a risk reduction associated
with crucifer consumption [120,121], and also some evidence for a risk reduction of for gastric cancer,
although the evidence is limited [122].
7.1. Food Processing
Because of their pungent taste, most crucifers are cooked prior to consumption. Two major cooking
processes that reduce GSL breakdown products are leaching of the water-soluble GSLs into cooking
water and heat inactivation of myrosinase. McNaughton and Marks estimated that on average 36% of
GSLs are lost following processing of crucifers [123]. However, actual losses will vary widely depending
on the precise cooking technique employed. Leaching of GSLs during boiling in water, the most common
cooking technique for crucifers in western countries, is estimated to lead to losses of between 25%–75%
of GSLs [124]. It is therefore noteworthy that in Mediterranean cuisine crucifer leaves are commonly
consumed as part of composite dishes in which the cooking liquor is also consumed (soups and stews).
Myrosinase is progressively inactivated by heat, hence reducing its capacity to generate bioactive
GSL breakdown products. Consuming crucifers raw will not only ensure that myrosinase remains active
but also avoid losses from leaching. Rocket (arugula) is the most common crucifer leaf consumed in
salads. In Mediterranean countries, both the cultivated form Eruca sativa and the wild form Diplotaxis
tenuifolia are consumed. Extracts of E. sativa reduced benzo(a)pyrene-induced genotoxicity against
human hepatoma (HepG2) cells [125] and had a range of cancer chemopreventive effects in cell culture
and animal models [126]. An isothiocyanate-rich extract of E. sativa was found to inhibit melanoma
growth and angiogenesis in mice [127]. A wide range of glucosinolates has been identified in E. sativa
and D. tenuifolia [128]. Unlike other glucosinolates, glucoerucin, the main glucosinolate found in
Eruca species, has direct antioxidant activity as well as acting as a precursor for the isothiosulphanate
erucin [129].
7.2. Implications
Since food processing strongly influences the levels of GSL breakdown products in cruciferous
vegetables this may impact on the health benefits of consuming these vegetables. This is suggested
in a case-control study that found that consuming raw crucifers was associated with a risk reduction
of bladder cancer (OR 0.64; 95% CI 0.42–0.97) whereas this was not observed for total crucifer
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consumption [130]. Apart from plant myrosinase, GSL breakdown products are also generated by
the action of gut bacteria. However, this is less efficient than by plant myrosinase [131]. Moreover,
relying on this as a means of generating GSL breakdown products is also less desirable because of the
wide variations between individuals in their capacity to breakdown GSLs; this has been attributed to
inter-individual variations in gut microflora composition [132].
Preparation techniques that retain cooking liquid (e.g., soups and stews) or that do not inactivate
myrosinase (e.g., consuming raw) will maximize available GSL breakdown products. Providing
myrosinase in the form of crucifer leaves is one way to compensate for losses of myrosinase activity.
Providing myrosinase in the form of a few raw crucifer leaves (broccoli sprouts) was found to enhance
conversion of a glucoraphanin-rich powder [133]. In Italy and Provence, salads that include a few rocket
leaves are popular and may be able to act in a similar way by enhancing the conversion of glucosinolates
from a dish of cooked crucifers in which the myrosinase has been inactivated. Blanching prior to freezing
is another process that inactivates myrosinase, and adding raw crucifer (0.25% daikon root) was able to
restore 100% of sulforaphane formation in frozen broccoli [134]. Hence, a few raw crucifer leaves may
also be useful when consuming frozen crucifers.
Although retaining GSLs might be desirable from a health point of view, GSL breakdown products are
responsible for the pungent taste of crucifers and hence many cultures prefer to consume these vegetables
cooked, a process which will reduce pungency but also GSLs. Both taste and texture affect the cooking
time chosen by consumers and the impact of these decisions on GSL content has been modeled for
broccoli consumption. This study found that the most common boiling time compatible with optimal
sensory acceptability (20 min) corresponded to a 20% to 80% reduction in GSL content (depending on
the amount of water added) [135]. In contrast to this usual convention in western cuisine of consuming
crucifers as a separate vegetable, crucifers in Mediterranean cuisine are frequently consumed as part of
composite dishes such as stews or soups. Here the taste of GSL breakdown products is complemented
by other flavors and higher levels of GSLs in the dish may be more acceptable. In the case of raw rocket
leaves where levels of GSL breakdown products cannot be manipulated by cooking, a sweetened salad
dressing may be added, although in a sensory analysis by a group of panelists the bitterness of rocket
was perceived as a positive attribute in itself [136]. Another source of GSLs in the traditional MD is
wild greens. The collection and consumption of wild greens remains an important part of the traditional
Mediterranean diet [137], and wild greens belonging to the crucifer family, such as wild mustards, will
add to the overall dietary intake of GSLs.
8. Alliums
The MD typically includes high consumption of onions and garlic. Two groups of phytochemicals
in alliums that have received particular attention for their putative health benefits are organo-sulfur
phytochemicals (thiosulfinates) and flavonoids. Thiosulfinates are volatile, unstable compounds
generated by the enzyme alliinase from precursors (S-alk(en)yl-L-cysteine sulfoxides). In garlic, alliin is
first converted by alliinase to allicin which then degrades to various compounds including ajoene, diallyl
sulfides and vinyldithiins. These compounds are rapidly metabolized in vivo [138], and one metabolite
of diallyl disulfide and diallyl trisulfide, hydrogen sulfide, is implicated in the vasoactive effects of
garlic [139]. Allicin has in vitro anti-bacterial action against H. pylori which is incriminated in stomach
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cancer [140]. High levels of flavonoids are present in onions and garlic; onions contain particularly
high levels of quercetin and kaempferol glucosides and garlic contains myricetin glucosides [141]. Both
organo-sulfur compounds and quercetin have antioxidant and anti-inflammatory properties [142,143].
As is the case for many individual fruits and vegetables, epidemiological studies of all sites cancer
risk and garlic intake are inconsistent because most cancer sites have specific modifying factors. The
World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) qualified the
level of evidence for a causal relationship between allium vegetable consumption and prevention of
stomach cancer and for colorectal cancer as probable [144]. For colorectal cancer, this was confirmed
in the WCRF/AICR Systematic Literature Continuous Update Project (CUP) of 2011 [145]. These
collective expertise reports have subsequently been confirmed by several studies. A recent review of
Southern European case-control studies (mostly Italian cohorts) suggested that high intakes of onion and
garlic decreased the risk for cancers of the oral cavity and pharynx, oesophagus, colorectum, larynx,
endometrium, ovary and kidney (garlic only) [81]. In addition, in a case control study raw garlic
consumption (two or more times per week) was inversely associated with lung cancer (OR 0.56; 95%
CI 0.44–0.72) [146]. The authors speculated that this may have been because the volatile oil from raw
garlic (which includes allicin and diallyl sulfides) is largely excreted in the lungs and hence may be
able to exert a beneficial effect there. In another meta-analysis of mostly case-control studies, combined
allium intake (garlic, onions and others) was significantly associated with reduced gastric cancer risk
(OR 0.54; 95% CI 0.43–0.65) [147]. However, a recent meta-analysis found no overall protective
effect of garlic consumption, even in the cohort studies which included garlic supplements [148].
There was considerable heterogeneity between studies and when only the case-control studies were
analyzed (excluding the cohort studies and supplements) there was a 37% risk reduction (combined risk
estimate = 0.63; 95% CI 0.48–0.82) in spite of significant heterogeneity in this sub-group analysis.
Garlic is also linked to reducing cardiovascular risk based on favorable effects in vitro and in animal
studies in preventing vascular inflammation and reactive oxygen species (ROS) production, increasing
nitric oxide, and inhibiting platelet aggregation. [149]. However, only modest effects on blood pressure
were described, and a recent Cochrane review of epidemiological studies found insufficient evidence
to determine if garlic provides a therapeutic advantage versus placebo in terms of reducing the risk of
mortality and cardiovascular morbidity in patients diagnosed with hypertension [150].
8.1. Food Processing
Although there is also some rationale from experimental studies that raw garlic may have beneficial
effects over and above cooked garlic for the prevention of cancer and CVD, there are too few
epidemiological studies to undertake this analysis [149,151]. Nevertheless, food processing may
differentially affect flavonoids and organo-sulfur compounds since they have distinct properties.
Leaching of water soluble compounds is less of an issue for onions and garlic since they usually form the
base of a dish that is consumed in its entirety. However, onions and garlic are frequently subject to high
temperature cooking by frying. After moderate frying (5 min), concentrations of quercetin glucosides
(quercetin 4-glucoside and quercetin 3,4 di-glucoside) in onions increased even when expressed on a
dry weight basis which may possibly be explained by loss of other soluble solids and/or increased
Nutrients 2015, 7 7938
extractability due to plant cell wall degradation [152]. Longer heat treatments (>10 min) decreased
levels of the quercetin glucosides.
The alliinase system is analogous to myrosinase in crucifers by being activated by damage to the
plant tissue and also by being susceptible to inactivation by heat. Crushing garlic and allowing time
for allicin to accumulate before heating improved the in vitro antiplatelet activity of garlic compared to
heating garlic without crushing. [153], and, similarly, conditions that retained thiosulfinate generation
in onions, such as heating whole intact onions, enhanced their anti-platelet activity [154]. However, the
relevance of these in vitro findings to in vivo is unclear because of the rapid metabolism of allicin that
occurs in vivo.
8.2. Implications
Whereas moderate cooking may enhance the bioavailability of quercetin glucosides in onions,
cooking is deleterious to the generation of organo-sulfur compounds. There is no evidence that alliin
is converted by gut bacteria to allicin, hence food processing is an important way of generating bioactive
organo-sulfur compounds. Although epidemiological evidence is currently lacking, evidence from
experimental studies suggests that typical Mediterranean dishes that include raw garlic or raw onions
may have greater protective effects than for heated garlic or onions where alliinase has been inactivated.
Crushing garlic (common in Spain) rather than chopping, and finely processing onion (such as the custom
of using grated onions in tagines) may also be beneficial by causing greater plant cell disruption which
increases alliinase activity.
9. Nuts
Nuts are an important component of the MD and have been shown to have significant health benefits,
especially against CVD and all-cause mortality (see [155,156] for recent meta-analyses). The Predimed
study found that when nuts (a combination of walnuts, almonds and hazelnuts) were given to enrich a
MD, they reduced the risk of incident CVD and of diabetes [157]. Data on cancer are currently too
limited to draw conclusions [158].
Nuts contain broadly similar constituents, and most nuts are rich sources of unsaturated fats (and low
in saturated fatty acids (SFA)), protein, arginine (a precursor of nitric oxide (NO), important for vascular
tone), fiber and a variety of minerals and vitamins including tocopherols, folate, Mg and Ca. However,
there are important differences between nuts. For example, although the predominant FA in most nuts is
MUFA (oleic acid), walnuts contain only low levels of MUFA and are high in PUFA (linoleic acid and
α-linolenic acid). α-Tocopherol predominates in almonds and hazelnuts but γ-tocopherol is the main
form in walnuts and pistachios [159]. Nuts are also excellent sources of antioxidant phenolics, with
some nuts having particularly high levels of proanthocyanidins and hydrolysable tannins (gallotannins
and ellagitannins) (see [160] for recent review). The stilbene trans-resveratrol occurs in peanuts and
resveratrol-3-β-glucoside (piceid) has recently been identified in almonds [161].
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9.1. Food Processing
Two common processing techniques that may influence the health benefits of nuts are removal of
the skins (pellicles) and roasting. The pellicle is a major source of “total antioxidant capacity” (TAC)
as measured by the FRAP (ferric reducing antioxidant potential) assay, particularly in walnuts where,
by one estimate, 95% of TAC was present in the pellicle [162]. In another study, removal of the
pellicle reduced TAC by approximately 36% in hazelnuts, 90% in walnuts and 55% in pistachios [163].
This reduction in TAC can be explained because the pellicle is the location for the majority of
phenolic antioxidants. For example, pistachio skins contain 70.27 mg of flavonoids/g fresh weight
(expressed as catechin equivalents) whereas the kernel contains only 0.46 mg of catechin equivalents/g
fresh weight [164]. Some nuts such as walnuts are almost always eaten with their pellicle whereas
others, such as peanuts, are usually eaten without it. Peanuts are the main type of nut consumed
in some non-Mediterranean countries, and so nut-derived antioxidant polyphenols may be lower in
these countries. However, nuts without their skins still contain various fat soluble antioxidants such
as tocopherols since these are present in the kernel [160].
Almond skin is an effective inhibitor of copper-induced oxidation of human LDL cholesterol [165].
However, the benefits of consuming the whole nut may be greater since antioxidant polyphenols
from almond skins were shown synergise with α-tocopherol to increase the resistance of LDL to
oxidation [166]. This may be explained by flavonoids recycling the radical generated by α-tocopherol
during inhibition of LDL oxidation [167]. Beneficial effects have been observed even for nuts without
their pellicles. For example, a recent crossover clinical study on 15 moderately hypercholesterolemic
subjects examined the differential effects of whole walnut, walnut oil, meat and skin on biomarkers for
cardiovascular disease risk [168]. Walnut oil favorably affected endothelial function, and whole walnuts
increased cholesterol efflux.
Nuts are sometimes consumed after roasting (which is typically between 140–180 ˝C). Roasting may
cause changes to nut lipids and phytochemicals and generate new products through the Maillard reaction.
Some studies [169] but not others [170] found small increases in trans-FAs after roasting, although levels
were not considered to be of a concern to health. Increases in lipid oxidation products (as measured
by Thiobarbituric Acid Reactive Substances—TBARs) following roasting correlated with the PUFA
content, and tocopherol levels were reduced by prolonged roasting [170]. Although roasting can reduce
antioxidant polyphenols in the nut skins, prolonged roasting can increase overall TAC. Possible reasons
for this have been suggested by Bullo and colleagues and include breakdown of polymeric polyphenols
to monomers, hydrolysis of glycosylated flavonoids, the decomposition of aglycones and the formation
of Maillard reaction products (MRPs) with antioxidant activity [171]. The Maillard reaction can also
lead to the production of harmful products. One such product, acrylamide, is produced by roasting,
especially in almonds at high temperatures, which is probably due to their high asparagine and reducing
sugar content [172]. Advanced glycation endproducts (AGEs), which are mostly pro-inflammatory, also
form when almonds [173] and other nuts [174] are roasted.
Although complex changes can occur to antioxidants in nuts during roasting, the effects of roasting
on oxidative stress have not been examined in clinical studies to the best of the authors’ knowledge. A
few clinical studies have examined the consequences of roasting on other health parameters. One study
comparing the effects of unprocessed with processed peanuts (whole raw, roasted unsalted, roasted salted
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or honey roasted peanuts, or ground peanut butter) found that none of the forms of peanuts induced a
change in body weight or lipid parameters (total, LDL-cholesterol and triglycerides) [175]. In a few
hypercholesterolemic subjects, total cholesterol, LDL-cholesterol and triglyceride concentrations were
reduced in the same way by unprocessed and by processed forms of peanuts. Similarly, both raw and
roasted almonds lowered LDL-cholesterol and total cholesterol [176].
9.2. Implications
It is likely that the health benefits of nuts result from many components in nuts such as their healthy
fat profile, high level of antioxidants, and high levels of arginine (which acts as a source of NO). In vitro
studies suggest that whole nuts (with their skins) that are either unroasted or only moderately roasted
will be optimal for health although clinical studies suggest that some lipid parameters are influenced
similarly by roasted or unroasted nuts. Although assessments of nut intake in the MD do not distinguish
between the type of nut, this could be a confounder, for example because of the significantly different
fatty acid profile for walnuts. Retaining the skin also improves storage since the skin acts as a protective
shield against oxidation of unsaturated fatty acids [177].
10. Meat
Low meat consumption is recommended as part of a MD. Red meat consumption was shown to
increase inflammatory biomarkers in healthy women [178] and thus meat may work in opposition to the
anti-inflammatory effects of many plant foods. Not only does a low meat diet reduce the DII [179], but
aspects of Mediterranean cuisine may also contribute to reducing the inflammatory effects of meat as
discussed below.
Red meat consumption is consistently associated in prospective studies with an increased risk of
obesity [180–183] and diabetes [184–190]. For CVD, two recent meta-analyses showed an increased
risk with red and processed meat, with a level of evidence of “probable” [191,192]. Cancers have also
been associated with meat consumption particularly colorectal cancer. Red meat and processed meat
have been analyzed separately, and the WCRF/AICR CUP qualified the level of evidence for a causal
association between red meat and processed meat and colorectal cancer as convincing [145]. Since
this study, six prospective studies [193–198], three meta-analyses [199–201] and one analysis of pooled
studies [202] have shown some inconsistencies in relation to processed meat which might be related
to different processing methods of meat between countries. However, the level of evidence for the
association remains probable to convincing and underlines the importance of processing methods. Two
prospective studies analyzed the relationship between prostate cancer and processed meat, and both
showed a significantly increased risk suggesting a positive association [203,204].
One group of compounds implicated in the adverse effects of cooked meat is MRPs. Most
MRPs in meat result from cooking at high temperatures, and although some MRPs contribute to the
desirable flavor of cooked meat, others, including heterocyclic amines (HCAs) and advanced glycation
endproducts (AGEs), are potentially harmful. HCAs are suspected carcinogens, whereas many AGEs
have pro-inflammatory activities and are incriminated in a wide range of chronic diseases [205].
Although below median consumption of meat is positively scored for in the MD, there is no
consideration of how cooking techniques, such as the degree of cooking or foodstuffs cooked with the
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meat, may modify the formation of pro-inflammatory or pro-carcinogenic MRPs. Here we briefly discuss
the evidence for adverse health effects of MRPs in meat especially in relation to inflammation, and we
then discuss if food processing techniques relevant to the MD may reduce their formation.
10.1. Heterocyclic Amines
Cooking meat at high temperatures generates a wide range of HCAs, and more than 25 have so far
been identified [206]. PhIP (2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine) is the most abundant
HCA detected in the human diet, followed by MeIQx (2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline)
and DiMeIQx (2-amino-3,4,8-trimethylimidazo(4,5-f)quinoxaline). In 1993 the International Agency for
Research on Cancer concluded that the evidence from animal studies was sufficient to claim that PhIP
and MeIQx are carcinogenic. Studies examining if HCAs contribute to the association between cooked
meat and colorectal cancer risk are inconsistent (reviewed in [207]). The results of a case-control study
strongly suggested an association with increased risk of breast cancer with high intake of well-done red
meat and MelQx among postmenopausal women only (P-trend = 0.002 and 0.003, respectively) [208].
The evidence for a causal relationship between processed meat and breast cancer is limited and mainly
observed in case-control studies where a genetic polymorphism in N-acetyltransferase 2 has been
investigated in relation to the presence of HCA in foods (e.g., [209]). However, recent evidence does
not suggest that polymorphisms in genes that metabolize HCAs (N-acetyltransferase 2 and CYP 1A12)
modify colon or breast cancer risk [210,211]. In the National Institutes of Health (NIH)—AARP Diet
and Health prospective study, there is suggestive evidence implicating HCAs found in red meat cooked
at high temperatures in gastric cardia and non-cardia adenocarcinomas although the association never
reached statistical significance [212].
10.2. Advanced Glycation Endproducts
AGEs result from dicarbonyl groups from carbohydrate degradation products reacting with an amino
terminal group. Although AGEs are mainly products of the Maillard reaction, they can also be formed
from the auto-oxidation of glucose or from the peroxidation of lipids into dicarbonyl groups due to
oxidative stress [213,214]. As well as coming from the diet, AGEs are also produced endogenously in
the body. Cooked meat is the major dietary source of AGEs in most countries, with fish, aged cheese
and roasted nuts being other sources [215].
Many in vitro studies have shown that AGEs increase oxidative stress and inflammation and this may
at least in part be mediated by binding of AGEs to a receptor (RAGE) [205]. A number of human
studies have demonstrated a link between dietary intake of AGEs and inflammation, although results
are not conclusive. From a recent systematic review of human intervention studies in both healthy
individuals and patients with an underlying disease (mostly commonly type 2 diabetes), the authors
concluded that the main effect was a decrease in inflammatory status on a low AGE diet, whereas
results for an increase in inflammatory status on a high AGE diet were less consistent [216]. The
response to AGEs may be related to the inflammatory status of the individual and the level of circulating
AGEs [216]. AGEs have been implicated as causal factors for a wide range of diseases, in particular for
type 2 diabetes [217,218] and also for memory decline and Alzheimer’s disease [219,220]. In a recent
study, a high level of circulating methylglyoxal (MG)—an AGE precursor—was shown to correlate with
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impaired cognition in humans and impaired learning and memory function and enhanced amyloid-β
accumulation in mice [221]. In addition, high dietary consumption of AGEs has been shown to be
associated with pancreatic cancer [222]. Despite this accumulating evidence, the role of AGEs in disease
pathology remains controversial and there are conflicting results both in preclinical and clinical studies,
not least because of the lack of a fully validated assay for measuring the AGE content of foods [14,214].
There is some limited evidence linking AGEs with the MD. In a population of Italian students, loss of
adherence to a MD correlated with an increased intake of AGEs [223]. A recent study that retrospectively
estimated AGE intake from various ecological and cohort studies showed that high adherence to a MD
resulted in a lower meat and dairy intake, both of which contained high levels of AGEs [215]. This study
then compared the extrapolated AGE intake to Alzheimer’s disease incidence in two cohorts (Washington
Heights-Inwood Community Aging Project cohorts from 1992 and 1999). They proposed a correlation
between AGE intake and Alzheimer’s disease incidence although further studies are required to validate
this study.
10.3. Food Processing
Several aspects of Mediterranean cuisine may contribute to reducing the inflammatory and
carcinogenic effects of meat that are mediated by MRPs. The Maillard reaction is a non-enzymatic
reaction that is influenced by a large range of factors. The reaction accelerates significantly at high
temperatures, with a doubling in the rate with a 10 ˝C increase in temperature [224] and levels of
AGEs in foods cooked at high temperatures are typically up to 100-fold above those found in uncooked
foods [174]. This is an important consideration for meat since it is cooked at a wide range of temperatures
ranging from 100 ˝C for poaching/stewing, 140–190 ˝C for frying, to over 200 ˝C for roasting and
barbecuing. For example, levels of carboxymethyl lysine (CML) (an AGE precursor) determined by
UPLC/MS were up to twice as high in roasted chicken compared to boiled chicken [225] The degree of
“doneness” also influences AGE formation, and CML levels were twice as high in a well-done roasted
beef joint compared to one roasted rare [225].
The Maillard reaction is low at acidic pH [214] and marinating beef with lemon juice or vinegar has
been shown to reduce subsequent AGE formation during roasting [214]. Marinating is commonly used
in traditional Mediterranean cooking to tenderize tough meat. Besides effects on pH, constituents in
commonly used marinades have been found to reduce the formation of MRPs including some types of
HCAs. In most cases, the reduction in HCA formation was attributed to the antioxidant activities of the
marinades. For example, marinating chicken breasts with red wine reduced PhIP by up to 88% [226],
marinating beef patties with garlic was especially effective at reducing the formation of MeIQx and
4,8-DiMeIQx [227], both MeIQx and PhIP were reduced by a rosemary extract [228]. VOO reduced
the formation of various HCAs in fried burgers to a greater extent than non-VOO [229]. Various
components in VOO may contribute to its ability to inhibit MRPs. Oleanolic acid—a main terpene
in olive oil and especially in olives [230]—has anti-glycative effects in diabetic mice [231]. There is a
good deal of interest in the development of oleanolic acid for the treatment of diabetes although multiple
mechanisms may be involved in its action [232]. Olive phenolics, added as olive mill waste water, trap
dicarbonyl compounds and are being studied as anti-glycative agents, but it is not known if VOO has
similar properties to the olive mill waste water [233].
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In Mediterranean cooking, meat is often cooked with other ingredients such as vegetables, fruits, herbs
and spices. A wide range of these foodstuffs have been shown to inhibit MRP formation, including both
HCAs [206] and AGEs [234]. For example, HCA formation in model systems comprising mixtures of
sugars and amino acids or meat extracts was inhibited by carotenoids from tomatoes [235] and a cherry
extract inhibited PhIP formation in beef patties by up to 93% [236]. However, not all studies have
been positive, and no significant differences in HCA levels were found between meat samples cooked in
the typical Portuguese way with garlic, wine, olive oil, onion, and tomato and in control meat samples
(cooked without other ingredients) [237]. Many foodstuffs typically used in Mediterranean meat dishes
including cinnamon, garlic and rosemary have been shown to inhibit the formation of AGEs in in vitro
and animal models [234].
10.4. Implications
Not only is the MD low in foods with potentially high HCA and AGE contents—such as cooked meat,
it is also high in foods with a low content of these MRPs—such as fish, grains, low-fat milk products,
fruits, and vegetables. Lamb—the meat traditionally consumed most frequently in the MD—has low
levels of AGEs compared to other meats [174]. The wide range of studies demonstrating that cooking
meat with plant foods such as vegetables, fruit, herbs and spices lowers HCA/AGE formation, suggests
that this could be a healthful attribute of Mediterranean cuisine in comparison to some other cuisines
where meat is more typically cooked on its own. The overall composition of a dish, rather than any
single factor such as cooking temperature, can be important for determining the formation of MRPs. Not
only can many foodstuffs inhibit MRP formation but there may also be a negative impact of combining
meat with sources of sugars. For example, fried battered/breaded cod (not a traditional technique in
Mediterranean cuisine) had significantly higher CML levels than when the fish was grilled/roasted,
and casseroled chicken had higher levels of CML than portions roasted on their own. This may be
because reducing sugars in the prepared dish are reacting with lysine residues in the protein [225]. The
consequences of heating food are complex and not all MRPs are equally harmful; indeed some are
beneficial and some MRPs have antioxidant and anti-inflammatory properties [238]. MRPs from foods
rich in protein and fat appear to be more damaging than MRPs from roasted coffee and the crust of bread.
This may be related to the higher content of the AGE precursors CML and MG in foods rich in protein
and fat [213].
Since the Maillard reaction generates products with favorable attributes such as color and aroma, the
aim—for optimum consumer acceptability—should not be to eliminate the Maillard reaction altogether
but rather to use cooking techniques that direct the reaction towards favorable products rather than
towards harmful ones [214]. Further research is clearly required to elucidate the roles of HCAs and
AGEs in health and their relation to food processing. The WCRF/AICR CUP in 2010 stated that “it
is probable that HCAs found on the surface of well-done meat can cause colon cancer in people with
genetic predisposition” but no recommendation was made to the general public [239]. In relation to
AGEs, recommendations for reducing AGE formation are strongest for diabetic patients and those with
kidney disease [214].
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11. Discussion
The importance of considering the MD as more than just its food components is widely recognized.
According to UNESCO’s broad definition, the MD includes “a set of skills, knowledge, rituals, symbols
and traditions concerning crops, harvesting, fishing, animal husbandry, conservation, processing,
cooking, and particularly the sharing and consumption of food” [240]. Other commentators have also
emphasized the importance to the MD of practices such as food preparation methods and physical
activity [241], eating patterns and the absence of, or type of, snacking between meals [242,243]. Recent
updates of the MD pyramid also emphasize “the production, selection, processing and consumption of
foods” and other aspects of the Mediterranean lifestyle [244] and this is summarized in Table 1. In
this review, we provide further evidence of the importance of these wider considerations. In particular,
we have identified several examples of food processing pertinent to the MD that can have a significant
impact on the nutritional qualities of foods such as olives, olive oil and vegetables that are consumed as
part of a MD.
Table 1. Selected examples of how food processing techniques influence the levels of













Pitting Ó Hydroxytyrosol [64]







Deep frying (heating to
180 ˝C)
Ó Hydroxytyrosol [67]
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Cooked in olive oil
Ò Lycopene bioavailability [107,108]
Ò Naringenin bioavailability [110]
Mechanical processing Ò Naringenin bioavailability [111]
Crucifers
Boiling Ó Glucosinolates [124]
Chopping Ò Isothiocyanates [123]
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Frying 5 min Ò Quercetin glucosides [152]
Frying > 10 min Ó Quercetin glucosides [152]
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Contrasting with this perspective, it is often considered that effectively promoting a MD in
non-Mediterranean countries requires taking into consideration the cultural cuisine of the country in
question, and allowing for the ways food items are typically prepared and cooked in the adopting
country [3,245]. This potentially creates a mismatch between tailoring the MD to non-Mediterranean
cuisines whilst at the same time respecting the specific cultural aspects of traditional Mediterranean
cuisine. Fortunately, advice on food processing pertinent to the MD is, in most cases, still compatible
with the cultural cuisine of consumers in non-Mediterranean countries, since it merely involves changing
cooking practices (such as stewing rather than boiling vegetables) or selecting healthier variants of foods
(e.g., of olives and olive oil). Further implications of food processing on the nutritional qualities of foods
are discussed more fully in the sections of this review for each food group.
At present, there is only limited information regarding the extent to which changing food
preparation and cooking practices influences levels of consumption of antioxidant and anti-inflammatory
phytochemicals. However, significant steps in this direction have been taken with the development of a
Retention Factor (RF) for polyphenols [246]. The RF is a measure of how levels of polyphenols in foods
change with food processing, and RF values have been incorporated into recent estimates of polyphenol
intake in cohorts from the EPIC study [247].
Further work is also required to establish if food processing influences health outcomes, and whether
or not this information should be incorporated into measures of adherence to the MD. Adherence
to the MD is usually determined by establishing a MD score for a population based on median
consumption of various food groups and then grouping subjects into quantiles based on their score
above or below the median value [248]. Upper versus lower quantile values typically vary 2–3 fold
for olive oil (in populations where olive oil is commonly consumed) [52] and 2–3 fold for vegetable
consumption [249]. This narrative review, and the more quantitative data from RF values from the
Phenol Explorer database [9], indicate that different cooking methods can also give rise to several-fold
differences in polyphenol content between vegetables, depending on the type of polyphenol and type of
vegetable. Hence, food processing practices may have a significant impact on the nutritional quality
of some foods in the MD, comparable in some circumstances to differences in intake between low
and high consumers. The use of the RF database will help capture the influence of food processing
on the nutritional values of some food groups within the MD. However, this database only applies to
polyphenols and, as discussed in this review, there are many other influences on the nutritional value
of food groups, and there are currently no databases that quantify these. In addition, there are practical
difficulties in capturing a level of precision in epidemiological studies beyond “raw” and “cooked” for
vegetables and “boiled” and “fried” for animal products, and this information is of limited value if it is
not translated by food composition tables. In the same way, the use of herbs and spice might be evaluated
by “yes” or “no” or, at the most, by frequency, but never quantitatively.
12. Conclusions
In this review, we have highlighted aspects of food processing pertinent to the MD that can influence
the nutritional quality of foods, and we also provide evidence that this may impact on health outcomes,
especially in relation to oxidative stress and inflammation. Currently, it is difficult to quantify this
impact. Nevertheless, recognizing that food processing influences the nutritional quality of foods may
Nutrients 2015, 7 7946
be important for public health campaigns promoting the MD and for epidemiological studies comparing
the health benefits of the MD between populations with different cooking practices.
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